Terence Kohler
Director of Finance/CFO chez VERRICA PHARMACEUTICALS INC.
Fortune : 440 543 $ au 31/03/2024
Profil
Terence Kohler is currently the Chief Financial Officer at Verrica Pharmaceuticals, Inc. Prior to this role, he served as the Treasurer & Vice President-Corporate Development at Endo International Plc from 2020 to 2021.
Mr. Kohler completed his undergraduate degree at Dickinson College and holds an MBA from The University of North Carolina at Chapel Hill and Kenan-Flagler Business School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
15/03/2024 | 74 416 ( 0,18% ) | 440 543 $ | 31/03/2024 |
Postes actifs de Terence Kohler
Sociétés | Poste | Début |
---|---|---|
VERRICA PHARMACEUTICALS INC. | Director of Finance/CFO | 16/07/2021 |
Anciens postes connus de Terence Kohler
Sociétés | Poste | Fin |
---|---|---|
ENDO INTERNATIONAL PLC | Treasurer | 01/07/2021 |
Formation de Terence Kohler
Dickinson College | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |